Browsing by Author Dalenc, Florence
Showing results 1 to 3 of 3
| Issue Date | Title | Author(s) |
|---|---|---|
| 17-Jun-2025 | Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial | Llombart Cussac, Antonio; Pérez García, José Manuel; Bellet Ezquerra, Meritxell; Dalenc, Florence; Gil Gil, Miguel; Ruiz Borrego, Manuel; Gavilá, Joaquín; Schmid, Peter; Zamora, Pilar; Wheatley, Duncan; Martínez de Dueñas, Eduardo; Amillano, Kepa; Di Cosimo, Serena; Antón, Antonio; Cottu, Paul-Henri; Shimizu, Eileen; Fernandez Pinto, Melissa; Sampayo Cordero, Miguel; Cortés, Javier |
| 1-Aug-2024 | Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer | Di Cosimo, Serena; Pérez García, José Manuel; Bellet Ezquerra, Meritxell; Dalenc, Florence; Gil Gil, Miguel; Ruiz Borrego, Manuel; Gavilá, Joaquín; Aguirre, Elena; Schmid, Peter; Marmé, Frederik; Gligorov, Joseph; Schneeweiss, Andreas; Albanell, Joan; Zamora, Pilar; Wheatley, Duncan; Martínez De Dueñas, Eduardo; Amillano, Kepa; Shimizu, Eileen; Sampayo Cordero, Miguel; Cortés, Javier; Llombart Cussac, Antonio |
| 27-Oct-2022 | Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study | Pérez García, José Manuel; Gebhart, Geraldine; Ruiz Borrego, Manuel; Schmid, Peter; Marmé, Frederik; Prat Aparicio, Aleix; Dalenc, Florence; Kerrou, Khaldoun; Colleoni, Marco; Braga, Sofía; Malfettone, Andrea; Sampayo Cordero, Miguel; Cortes, Javier; Llombart Cussac, Antonio |